Search
for
Sort by
Research 721–750 of 1000+
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- What Is the Male Polycystic Ovary Syndrome Phenotype?
- An Approach to the Patient with Hirsutism
- The association between dyslipidemia and androgenic alopecia: A cross-sectional study from the PERSIAN Guilan cohort study
- Patients with vitiligo present fewer cardiovascular risk factors: results from a case–control study
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- POLİKİSTİK OVER SENDROMU FENOTİPLERİ VE METABOLİK DİSFONKSİYON İLİŞKİSİ
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Comparison of Components of Metabolic Syndrome in Androgenic Alopecia versus Healthy Population
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Absence of Interaction Between 5α‐Reductase Inhibitors and Glucocorticoids on Incidence of Myocardial Infarction in People With Type 2 Diabetes
- Testosterone, Dihydrotestosterone, and Incident Cardiovascular Disease and Mortality in the Cardiovascular Health Study
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women
- Cross-sectional study of the association between skin tags and vascular risk factors in a bariatric clinic-based cohort of Irish adults with morbid obesity
- Cutaneous Clues to Metabolic Dysfunction: Dermatological Manifestations of Diabetes and Insulin Resistance in Clinical Practice
- The Comparison of Metabolic Syndrome Parameters, Trichoscopic and Trichoscan Characteristics in Androgenetic Alopecia (AGA) and Early-Onset Androgenetic Alopecia (Early-Onset AGA)
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years
- Association of metabolic syndrome with female pattern hair loss in women: A case-control study
- Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome?
- Condylomata acuminata of HIV-positive men may harbour focal areas of dysplasia: relevant implications for the management of human papillomavirus-induced disease in high-risk patients
- Metabolic syndrome in alopecia areata: an observational study at a tertiary care center
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- Finasteride for prostatic disease: an updated and comprehensive review
- Testosterone metabolite nonessential for androgen effects